Herpes zoster following recombinant COVID-19 vaccine: A case series

Abstract

The ongoing novel coronavirus pandemic caused by the SARS-COV-2 virus has severely affected the global population. As various vaccines are being introduced to combat this virus, several adverse effects are being commonly reported such as mucocutaneous reactions, local injection site reactions, and delayed hypersensitivity reactions manifesting as “COVID arm.” However, uncommon side effects like reactivation of certain viruses are also being recently reported. We are reporting three cases of herpes zoster which occurred following the first dose of the recombinant COVID-19 AZD1222 vaccine, to generate awareness about this uncommon sequel.

Keywords

• covid-19
• covid-19 vaccine
• herpes zoster